STOCKHOLM--(BUSINESS WIRE)--Regulatory News: RaySearch Laboratories AB (STO:RAYB) announces that version 3.0 of RaySearch’s RayStation® treatment planning system has been released for clinical use in the European Union, USA, Japan and Australia and is pending regulatory approval in Canada, China, New Zealand and South Korea. The new version includes a wide range of new features and improvements.
